David A. Siegel Evolus, Inc. Transaction History
Two Sigma Advisers, LP
- $47 Billion
- Q3 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Evolus, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 26,500 shares of EOLS stock, worth $191,330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,500
Previous 76,200
65.22%
Holding current value
$191,330
Previous $701,000
76.89%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding EOLS
# of Institutions
172Shares Held
50.5MCall Options Held
175KPut Options Held
539K-
Nantahala Capital Management, LLC New Canaan, CT5.73MShares$41.3 Million1.43% of portfolio
-
Tang Capital Management LLC San Diego, CA5.49MShares$39.6 Million1.53% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$28.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$24.8 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA2.63MShares$19 Million0.68% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $405M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...